• Home
  • About
  • All Companies
    • Recent
    • Summary Lists
  • Contact

BacVax

  • June 15, 2022
  • New Biotech Startups

BacVax is a spin-off from the University of Arizona with a novel approach to developing vaccines against bacterial infections by mapping the proteins on the surface of bacteria.

BacVax’s approach involves bioinformatic analyses of genome sequences paired with protein structure analysis to identify protein regions that are: present in every strain in the species; on the surface for access by the immune system; 100% sequence conserved; and long enough to function as an immune target.

BacVax also uses a novel delivery system, Bacterial Vaccine Polypeptides, to efficiently deliver the Vaccine Targets of multiple proteins, thus stimulating an immune response that attacks bacteria at multiple sites.

The company says that because its method is based on genomic and structural vaccinology, any bacteria can be analyzed for targets. This means its vaccines should be able to address bacterial infections that currently have no vaccine options available, such as ear infections and exacerbations of chronic obstructive pulmonary disease.

BacVax views bacterial vaccines as a safer long-term alternative to frequent antibiotic for both humans and animals.


Subscribe for alerts on new companies featured on Startups.Bio


January 25, 2023MxT Biotech
MxT Biotech, a Korea University spin-out, aims to transform cancer immunotherapy, cellular engineering and genome editing with its patented non-viral genome editing technology. The Hydroporator™ is a non-viral microfluidic platform …
November 25, 2022Vilya
Vilya is a spin-out of the University of Washington Institute for Protein Design (IPD), with a platform to design membrane-permeable peptides with high structural accuracy, opening up a new class …
November 16, 2022VentureRadar’s Top 100 Emerging Biotech Start-ups Report
Biotechnology is in the midst of a exciting era of innovation, with an ever-expanding toolbox of modalities and approaches spawning development of exciting new vaccines, medicines and therapies. VentureRadar's Top …
November 2, 2022CorriXR Therapeutics
CorriXR Therapeutics is an oncology-focused biotherapeutics developing a novel gene editing platform technology. CorriXR has developed an innovative CRISPR/Cas molecule that disables the genome of a tumor cell but not …

View all recently featured startups


Tags:

© Copyright 2022. Startups.Bio, powered by VentureRadar.